Navigation Links
Cardiac patients given longer prescriptions at discharge more likely to continue taking medication
Date:6/28/2013

Elderly cardiac patients prescribed heart medications for 60 days or more after leaving hospital have four times the odds of adhering to the drug regime than patients prescribed the same medications for 30 days, according to research conducted at the Institute for Clinical Evaluative Sciences (ICES) and Women's College Hospital (WCH).

The study, published today in the Canadian Journal of Cardiology, found longer initial prescriptions when leaving hospital are associated with long-term adherence in elderly patients. The findings suggest prescriptions covering a longer interval of time are both more patient-centered and more effective.

"Studies show that adherence to cardiac medications after a cardiac event like a heart attack declines over time. But we know that taking these medications for the long-term is absolutely essential for preventing further cardiac events," said Dr. Noah Ivers, lead author of the study and family physician at Women's College Hospital. "This study shows that longer prescriptions for cardiac patients after leaving hospital increase the likelihood that patients will take the medications for the long term, which may reduce their risk of heart attacks, stroke or even death."

In the study, researchers investigated medication adherence of more than 20,000 elderly patients with coronary artery disease to three common classes of cardiac medications ACE inhibitors, beta blockers and statins. For an 18-month period, the researchers compared the results of those prescribed the medications for less than 30 days, for 30-60 days and for 60 days or more. They found:

  • Patients prescribed the medication for 60 days or more were more likely to adhere to the medication in the long term than those prescribed the medication for 30 days or less
  • Older patients were less likely to adhere to medications.
  • Male patients were more likely to continue to take some medications but not others.
  • Up to 50 per cent of prescriptions covered only 7 days.
  • More than 80 per cent of patients had a follow-up appointment within one month, regardless of prescription length.

"The majority of patients in our study left hospital with a prescription for cardiac medications for 30 days or less," said Dr. Ivers. "This may be a result of the common clinical perception that short prescriptions encourage patients to go to their followup appointments, yet our study found regardless of the duration of the prescription, nearly all patients did, in fact, attend their followup appointment."

Short prescriptions may inadvertently suggest to patients and family physicians alike that long-term adherence isn't necessary, the authors suggest.

"When we reduce the requirement for early refills, patients still follow up with their family physician or cardiologist and they are more likely to remain on the medications as well, Dr. Ivers said. "We certainly want to encourage early outpatient follow up after hospitalization, but holding medications ransom may not be the best way to do it."

Modifying the length of a prescription is an easy fix, Dr. Ivers adds.

"Forcing elderly patients to frequently visit their cardiologist or family physician to renew prescriptions is only exacerbating the problem," he said. "While dosage adjustments are sometimes required, increasing the duration of a prescription for cardiac patients can easily be done, leading to significant benefits for patients."


'/>"/>

Contact: Julie Saccone
julie.saccone@wchospital.ca
416-323-6400 x4054
Women's College Hospital
Source:Eurekalert

Related medicine news :

1. SMART heart eases heart ache, targets cardiac patients emotional well-being
2. Erectile dysfunction drug may benefit cardiac function in young patients with heart defects
3. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
4. People With HIV at Higher Odds of Sudden Cardiac Death
5. Study: Heart damage after chemo linked to stress in cardiac cells
6. Study Spots Early Warning Signal for Sudden Cardiac Death
7. Wake Forest Baptist study suggests Tasers dont cause cardiac complications
8. Are cardiac risk factors linked to less blood flow to the brain?
9. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
10. Coordinated Care Boosts Cardiac Arrest Survival: Study
11. Implementing a therapeutic hypothermia program for post-cardiac arrest in acute care hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... 2017 , ... Support of value-based care models requires collaboration across all facets ... industry solutions, Fogo Data Centers announces the launch of the Fogo Partner Community™. , ... one in which all systems work well, work together, and work together well. ...
(Date:2/21/2017)... (PRWEB) , ... February 21, ... ... of technology-enabled clinical trial solutions, today announced the further expansion of its ... applications they can leverage as part of Bioclinica’s extensive and growing eHealth ...
(Date:2/21/2017)... ... February 21, 2017 , ... Atlanta-based Jvion, ... analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to date, received ... giants including Accenture, GE Ventures, and Software AG , will bring top ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... chronically untreated despite the medical, mental health, and financial consequences of inaction. On ... to take action if they have concerns about their hearing. , Effective treatment ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... protein espresso drinks, announced its products are now available for purchase on RonnieColemanNutrition.com, ... Drink Mix has become popular among health-conscious consumers who love coffee but are ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Liver Cirrhosis Drugs Price Analysis and Strategies ... Cirrhosis market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Liver Cirrhosis ...
(Date:2/21/2017)... and Markets has announced the addition of the "Rosacea Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Rosacea ... market? What are the unit prices and annual treatment ...
(Date:2/21/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Anthrax Drugs Price Analysis and Strategies - 2016, provides drug ... research answers the following questions: What are the ... positioned in the Global Anthrax market? What are the ...
Breaking Medicine Technology: